Xilinx CEO Announces Retirement
SAN JOSE, Calif. -- Aug. 7, 2007 -- Xilinx, Inc. today announced that Willem P. Roelandts, 62, President, Chief Executive Officer and Chairman of the Board intends to retire from the positions of President and Chief Executive Officer. A committee of the Company's Board of Directors has been formed to begin an immediate search for a successor, evaluating both external and internal candidates. Roelandts will remain Chief Executive Officer until a successor is named. Upon retirement, Roelandts will continue to serve as Chairman of the Board.
At the helm of Xilinx since 1996, Roelandts led the company through an intense period of change within the semiconductor industry, growing Xilinx sales from $560 million to over $1.8 billion. During his tenure, Roelandts significantly expanded the Company's global business and initiated its successful market diversification strategy to better address high-growth end markets, including consumer, automotive, industrial and defense. These markets have grown from 12 percent of total revenues in fiscal year 2002 to 45 percent of total revenues today.
About Xilinx
Xilinx, Inc. (NASDAQ: XLNX) is the worldwide leader of programmable logic solutions. Additional information about Xilinx is available at http://www.xilinx.com.
|
Xilinx, Inc. Hot IP
Related News
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |